-
Symbol
-
SLXN on Nasdaq
-
Investment type
-
Equity - Shares of Stock
-
Class
-
Ordinary Shares, par value $0.0009 per share
-
Latest Disclosed Ownership
-
112K shares
-
Security Ownership
-
6.6%
THE GOLDMAN SACHS GROUP, INC. ownership in Silexion Therapeutics Corp Ordinary Shares, par value $0.0009 per share (SLXN)
2025-02-10 - THE GOLDMAN SACHS GROUP, INC. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 112K shares of Silexion Therapeutics Corp Ordinary Shares, par value $0.0009 per share (SLXN).
This represents 6.6% percent ownership of the company.